Skip to main content

Robert S. Ohgami, MD, PhD

Languages spoken: English
  • Dr. Robert Ohgami was an undergraduate at Princeton University and an MD/PhD MSTP student in Harvard-MIT’s Health Sciences and Technology Program (HST). He went on to complete residency and fellowship at Stanford University in anatomic pathology and hematopathology.

    He has been a research and clinical faculty member at Stanford University and UCSF and served in leadership positions as a Director of the Molecular Pathology Core, Associate Program Director in Anatomic Pathology, and a Division Chief of Hematopathology. He is an Associate Editor for Frontiers in Oncology, on the editorial board of several journals including the Journal of Molecular Diagnostics, and a contributing author for the 2022 hematopathology WHO blue book. After several years of running an independently funded translational research lab, he was honored with a Berard-Dorfman Founders award in 2016 for his work in Hematopathology.

    Dr. Ohgami is a Professor of Pathology at the University of Utah and Chief Medical Director for Research and Development in Integrated Oncology and Genomics at ARUP.

    Board Certification and Academic Information

    Academic Departments Pathology - Primary
    Academic Divisions
  • Dr. Robert Ohgami was an undergraduate at Princeton University and an MD/PhD MSTP student in Harvard-MIT’s Health Sciences and Technology Program (HST). He went on to complete residency and fellowship at Stanford University in anatomic pathology and hematopathology.

    He has been a research and clinical faculty member at Stanford University and UCSF and served in leadership positions as a Director of the Molecular Pathology Core, Associate Program Director in Anatomic Pathology, and a Division Chief of Hematopathology. He is an Associate Editor for Frontiers in Oncology, on the editorial board of several journals including the Journal of Molecular Diagnostics, and a contributing author for the 2022 hematopathology WHO blue book. After several years of running an independently funded translational research lab, he was honored with a Berard-Dorfman Founders award in 2016 for his work in Hematopathology.

    Dr. Ohgami is a Professor of Pathology at the University of Utah and Chief Medical Director for Research and Development in Integrated Oncology and Genomics at ARUP.

    Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Academic Divisions

    Education history

    Fellowship Immunology - Stanford University School of Medicine Postdoctoral Fellow
    Hematopathology - Stanford University School of Medicine Fellow
    Residency Anatomic Pathology - Stanford University School of Medicine Resident
    Health Sciences and Technology Program - Harvard Medical School-Massachusetts Institute of Technology
    Graduate Training Cell and Developmental Biology - Harvard University Ph.D.
    Medicine - Harvard Medical School M.D.
    Undergraduate Molecular Biology - Princeton University A.B.